OZYMF
Strategic Partners A/S
Set alert
90.00 USD 0.00 0.00%
0.09 Day range 0.091
0.09 52-week range 90.00
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.091
- Prev close
- 90.00
- Mkt cap
- 4.84M
- Vol
- 3.25K
- Avg vol
- 0
- EPS
- -2,471.19
- P/E
- 0.00
More statistics
- Low
- 0.09
- High
- 0.091
News
- Orphazyme completes sale of substantially all of its assets and business activities to KemPharm
- Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc.
- Why Entera Bio, Orphazyme, Bellerophon Are Moving Today
- Kim Stratton, CEO, resigns from Orphazyme
- CytRx Highlights Orphazyme's Submission of European Marketing Authorisation for Arimoclomol to Treat Niemann-Pick Disease Type C
- Orphazyme closes its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe
- Orphazyme announces U.S. FDA acceptance and Priority Review of New Drug Application for arimoclomol for Niemann-Pick disease Type C
- Stocks That Hit 52-Week Highs On Thursday
Your note
Sign in to keep a note on OZYMF — it syncs with the Stock Master app.